OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Truist upgrades AMD to Buy, sees AI traction driving stock higher

Could Alphabet Be About to Start Mining Bitcoin?

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
Nvidia stock jumps to highest levels since January with record high close in sight
Uncategorized

Nvidia stock jumps to highest levels since January with record high close in sight

June 24, 2025

Nvidia shares jumped Tuesday, putting the stock on track to end the trading session at its highest level since its record close in January.

Spreedly Announces Just-In-Time Card Updates for Visa Cards to Reduce Failed Payments
Uncategorized

Spreedly Announces Just-In-Time Card Updates for Visa Cards to Reduce Failed Payments

June 24, 2025

Spreedly (www.spreedly.com), a leading global open payments platform, today announced a strategic enhancement to its platform through the integration of Just...

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug
Uncategorized

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

June 24, 2025

Novo Nordisk has ended a partnership with the telehealth company that lasted less than two months.

Billionaire David Tepper Sold 97% of Appaloosa’s Nvidia Stake and His Entire Position in AMD in Favor of This Trillion-Dollar Artificial Intelligence (AI) Stock
Uncategorized

Billionaire David Tepper Sold 97% of Appaloosa’s Nvidia Stake and His Entire Position in AMD in Favor of This Trillion-Dollar Artificial Intelligence (AI) Stock

June 24, 2025

Appaloosa’s billionaire chief appears to be shifting his focus within the artificial intelligence (AI) arena.

Watch These Tesla Levels as Stock Soars Following Robotaxi Service Rollout
Uncategorized

Watch These Tesla Levels as Stock Soars Following Robotaxi Service Rollout

June 23, 2025

Tesla shares jumped 8% on Monday after the EV maker launched its highly anticipated autonomous robotaxi vehicle service on Sunday. Monitor these key chart...

3rdPartyFeeds

Jensen Huang Starts Selling Nvidia Stock Under $865 Million Plan

June 23, 2025

(Bloomberg) -- Nvidia Corp. Chief Executive Officer Jensen Huang has started selling the chipmaker’s stock, his first transactions under a plan that allows him...

3rdPartyFeeds

Better Artificial Intelligence Stock: BigBear.ai vs. C3.ai

June 23, 2025

Nations are ramping up artificial intelligence capabilities, and the U.S. is determined to lead the world in AI. BigBear.ai and C3.ai are helping the U.S...

Amazon to invest $54 billion in Britain over next three years
Uncategorized

Amazon to invest $54 billion in Britain over next three years

June 23, 2025

LONDON (Reuters) -Amazon has deepened its commitment to Britain, with the e-commerce giant saying it plans to invest 40 billion pounds ($54 billion) over the...

Tesla stock pops 8% after ‘foundational’ robotaxi launch in Austin
Uncategorized

Tesla stock pops 8% after ‘foundational’ robotaxi launch in Austin

June 23, 2025

Tesla stock popped as its robotaxi test kicked off smoothly on Sunday, with investors and Tesla enthusiasts breathing a sigh of relief, at least for now.

Eli Lilly seeks green light for weekly insulin after strong trial results
Uncategorized

Eli Lilly seeks green light for weekly insulin after strong trial results

June 23, 2025

While still an injectable, once-weekly dosing offers a simpler treatment regimen for patients.

Previous 1 … 70 71 72 73 74 … 8,351 Next
Indices by TradingView

Truist upgrades AMD to Buy, sees AI traction driving stock higher

August 26, 2025

Could Alphabet Be About to Start Mining Bitcoin?

August 26, 2025
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

August 26, 2025
Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

August 26, 2025
Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

August 25, 2025

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.